ArticleBMC cancer2014
Estimation of savings of life-years and cost from early detection of cervical cancer: a follow-up study using nationwide databases for the period 2002-2009.
Article in BMC cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Stage-Specific Healthcare Costs in Cervical Cancer and Cervical Intraepithelial Neoplasia: A Population-Based Analysis Informing Value-Based Oncology and Equitable Prevention.Current oncology (Toronto, Ont.) · 2026Article
- A method of estimating cervical cancers prevented by the introduction of national screening in Ireland.European journal of public health · 2026Article
- A large-scale, multi-centre validation study of an AI-empowered blood-based test for multi-cancer early detection.NPJ precision oncology · 2025Article
- Disease Burden of 30 Cancer Groups in Taiwan from 2000 to 2021.Journal of epidemiology and global health · 2025Article
- The trend of DALY of breast, colorectal, oral, and cervical cancers in Taiwan in 2005-2017.Heliyon · 2025Article
- A panel of seven protein tumour markers for effective and affordable multi-cancer early detection by artificial intelligence: a large-scale and multicentre case-control study.EClinicalMedicine · 2023Article
- Epidemiological/Disease and Economic Burdens of Cervical Cancer in 2010-2014: Are Younger Women at Risk?Healthcare (Basel, Switzerland) · 2023Article
- Preventive Cancer Screening in Asian Americans: Need for Community Outreach Programs.Asian Pacific journal of cancer prevention : APJCP · 2022Article
- Review
- Lifetime Risks, Life Expectancy, and Health Care Expenditures for Rheumatoid Arthritis: A Nationwide Cohort Followed Up From 2003 to 2016.Arthritis & rheumatology (Hoboken, N.J.) · 2021Article
- The Burden of Cervical Cancer in Korea: A Population-Based Study.International journal of environmental research and public health · 2020Article
- Association of Neighborhood Measures of Social Determinants of Health With Breast, Cervical, and Colorectal Cancer Screening Rates in the US Midwest.JAMA network open · 2020Article
- Estimating health benefits and cost-savings for achieving the Healthy People 2020 objective of reducing invasive colorectal cancer.Preventive medicine · 2018Article
- Lifetime risks, loss of life expectancy, and health care expenditures for 19 types of cancer in Taiwan.Clinical epidemiology · 2018Article
- Use of Chinese Medicine Reduces the Development of Cervical Cancer from Pap Smear-Diagnosed Cervical Dysplasia: A Case-Control Study.Evidence-based complementary and alternative medicine : eCAM · 2017Article
- Health expenditures spent for prevention, economic performance, and social welfare.Health economics review · 2016Article
- Sulforaphane, a Dietary Isothiocyanate, Induces G₂/M Arrest in Cervical Cancer Cells through CyclinB1 Downregulation and GADD45β/CDC2 Association.International journal of molecular sciences · 2016Article
- Canadian cancer screening disparities: a recent historical perspective.Current oncology (Toronto, Ont.) · 2015Article
- Noncommunicable Diseases Prevention and Cure: Work Performance and Gender Disparities in Mortality Risk.Inquiry : a journal of medical care organization, provision and financingArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFew studies consider both the survival and financial benefits of detection of invasive cervical cancer (ICC) at earlier stages. This study estimated the savings in life-years and costs from early diagnosis of cervical cancer using an ex post approach.
methodsA total of 28,797 patients diagnosed with cervical cancer in the period 2002-2009 were identified from the National Cancer Registry of Taiwan, and linked to the National Mortality Registry until the end of 2011. Life expectancies (LE) for cancer at different stages were estimated using a semi-parametric extrapolation method. The expected years of life lost (EYLL) for cancer were calculated by subtracting the LE of the cancer cohort from that of the age-and sex-matched general population. The mean lifetime costs after diagnosis paid by the single-payer National Health Insurance during (NHI) 2002-2010 were estimated by multiplying average monthly expenditures by the survival probabilities and summing up over lifetime.
resultsICC at stages 1 to 4 had an average EYLL of 6.33 years, 11.64 years, 12.65 years, and 18.61 years, respectively, while the related lifetime costs paid by the NHI were $7,020, $10,133, $11,120, and $10,015 US dollars, respectively; the younger the diagnosis age, the higher the savings with regard to EYLL. The mean lifetime costs of managing cervical cancer were generally lower for the earlier stages compared with stages 3 and 4.
conclusionsEarly detection of ICC saves lives and reduces healthcare costs. These health benefits and monetary savings can be used for cost-effectiveness assessments and the promotion of regular proactive screening, especially among older women.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.